HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Nakamura Selected Research

4-anisic acid (p-anisic acid)

3/2000Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Nakamura Research Topics

Disease

68Neoplasms (Cancer)
03/2018 - 01/2000
18Hypertension (High Blood Pressure)
12/2012 - 03/2000
17Neoplasm Metastasis (Metastasis)
10/2015 - 03/2000
15Inflammation (Inflammations)
01/2020 - 03/2000
12Bone Resorption
04/2015 - 01/2000
12Carcinoma (Carcinomatosis)
03/2015 - 01/2000
12Atopic Dermatitis (Atopic Eczema)
03/2006 - 05/2000
11Infections
12/2018 - 09/2000
10Stomach Neoplasms (Stomach Cancer)
11/2016 - 01/2000
10Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2013 - 01/2000
10Insulin Resistance
12/2008 - 01/2005
10Atherosclerosis
11/2008 - 05/2000
10Hepatocellular Carcinoma (Hepatoma)
09/2008 - 02/2000
9Stroke (Strokes)
04/2015 - 03/2000
9Hemorrhage
01/2013 - 11/2000
9Diabetes Mellitus
04/2008 - 08/2000
9Liver Diseases (Liver Disease)
01/2006 - 01/2000
8Heart Failure
08/2018 - 03/2000
8Osteoporosis
01/2015 - 07/2000
8Cardiovascular Diseases (Cardiovascular Disease)
06/2009 - 01/2004
7Alzheimer Disease (Alzheimer's Disease)
04/2015 - 10/2001
7Type 2 Diabetes Mellitus (MODY)
11/2008 - 08/2000
7Diabetic Retinopathy (Retinopathy, Diabetic)
01/2006 - 11/2001
6Melanoma (Melanoma, Malignant)
01/2019 - 12/2000
6Interstitial Lung Diseases (Interstitial Lung Disease)
02/2018 - 03/2000
6Carcinogenesis
11/2016 - 01/2000
6Body Weight (Weight, Body)
11/2015 - 10/2000
6Lymphatic Metastasis
10/2009 - 01/2000
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2008 - 05/2000
6Necrosis
07/2008 - 11/2000
6Reperfusion Injury
02/2003 - 03/2001
5Systemic Scleroderma (Systemic Sclerosis)
04/2019 - 01/2016
5Fibrosis (Cirrhosis)
02/2018 - 04/2000
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 07/2001
5Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 04/2001
5Lymphoma (Lymphomas)
01/2014 - 08/2000
5Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2007 - 01/2005
5Pancreatic Neoplasms (Pancreatic Cancer)
02/2007 - 11/2002
5Diabetic Angiopathies (Diabetic Angiopathy)
01/2007 - 01/2003
5Parkinson Disease (Parkinson's Disease)
09/2001 - 06/2000
4Pathologic Constriction (Stenosis)
11/2021 - 01/2000
4Esophageal Neoplasms (Esophageal Cancer)
06/2018 - 11/2016
4Disease Progression
04/2016 - 10/2001
4Adenocarcinoma
03/2015 - 01/2000
4Endometrial Neoplasms (Endometrial Cancer)
10/2013 - 01/2005
4Prostatic Neoplasms (Prostate Cancer)
06/2012 - 08/2001
4Rheumatoid Arthritis
01/2011 - 02/2000
4Fever (Fevers)
06/2009 - 01/2000
4Thrombosis (Thrombus)
03/2009 - 10/2000
4Diabetic Nephropathies (Diabetic Nephropathy)
07/2007 - 05/2000
4Proteinuria
01/2007 - 05/2000
4Aneurysm (Aneurysms)
12/2006 - 05/2000

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2000
18Advanced Glycation End ProductsIBA
12/2008 - 01/2003
12CytokinesIBA
01/2020 - 03/2000
11Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2005
10Pharmaceutical PreparationsIBA
01/2005 - 01/2000
9Indicators and Reagents (Reagents)IBA
08/2018 - 07/2000
8AntibodiesIBA
01/2019 - 01/2000
8Messenger RNA (mRNA)IBA
02/2017 - 02/2000
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 02/2000
8EnzymesIBA
10/2008 - 04/2000
7CalciumIBA
07/2011 - 10/2000
6Alanine Transaminase (SGPT)IBA
06/2019 - 01/2000
6AntigensIBA
11/2009 - 12/2000
6pigment epithelium-derived factorIBA
03/2009 - 01/2005
6Insulin (Novolin)FDA Link
09/2008 - 10/2001
6Reactive Oxygen Species (Oxygen Radicals)IBA
11/2007 - 02/2000
5GemcitabineFDA Link
12/2019 - 10/2000
5Cisplatin (Platino)FDA LinkGeneric
12/2019 - 07/2000
5Vitamin DFDA LinkGeneric
11/2015 - 09/2001
5CollagenIBA
09/2015 - 03/2000
5Glycoproteins (Glycoprotein)IBA
12/2014 - 08/2001
5Phosphotransferases (Kinase)IBA
08/2012 - 10/2000
5ImmunosorbentsIBA
10/2008 - 04/2000
51,4-dihydropyridine (dihydropyridine)IBA
11/2007 - 01/2005
5Immunoglobulin E (IgE)IBA
11/2007 - 02/2001
5Nifedipine (Adalat)FDA LinkGeneric
11/2007 - 01/2005
5aniracetamIBA
10/2001 - 03/2000
5Dopamine (Intropin)FDA LinkGeneric
10/2001 - 01/2000
4Prednisolone (Predate)FDA LinkGeneric
06/2017 - 06/2000
4Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 03/2000
4hydroxide ionIBA
11/2015 - 07/2000
4C-Reactive ProteinIBA
07/2011 - 03/2000
4Triglycerides (Triacylglycerol)IBA
09/2010 - 06/2001
4PPAR gammaIBA
09/2008 - 12/2006
4Telmisartan (Micardis)FDA Link
09/2008 - 12/2006
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2007 - 01/2005
4Monoclonal AntibodiesIBA
01/2007 - 01/2001

Therapy/Procedure

44Therapeutics
10/2017 - 01/2000
18Drug Therapy (Chemotherapy)
10/2017 - 01/2000
12Radiotherapy
01/2018 - 01/2000
7Gastrectomy
11/2016 - 01/2000
5Hysterectomy
10/2013 - 01/2000
4Chemoradiotherapy
10/2017 - 01/2001
4Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2017 - 05/2000
4Hematopoietic Stem Cell Transplantation
01/2017 - 05/2004
4Activities of Daily Living (ADL)
08/2010 - 08/2000
4Oral Administration
10/2009 - 11/2001
4Thoracotomy
12/2006 - 08/2000